Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369148
Status:
COMPLETED
Last Update Posted:
2009-08-26
First Post:
2006-08-28
Brief Title:
Combination of Glinides With Premixed Insulin
Sponsor:
Keio University
Organization:
Keio University
Study Overview
Official Title:
Evaluation of Usefulness of Combination Therapy of Rapid Acting Insulin Secretagogue Glinide With Premixed Insulin in Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Combination therapy of glinides with premixed insulin provides better glycemic control than premixed insulin alone
Detailed Description:
Type 2 diabetic patients undergoing twice daily injections of premixed insulin are administered glinides 10mg of mitiglinide or 90 mg of nateglinide at lunchtime without changing their insulin regimen Twelve weeks after administration of the glinides they are discontinued HbA1c levels at the start of glinide administration 12 weeks after administration and 12 weeks after discontinuation are measured
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None